Essais liés2clinical trials
VilleZhengzhoulocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT05810038

Ouvrir le site du centre

Essais cliniques associés

2
MoléculeIndication / populationPhaseNCTTitreStatut
Rimegepant Migraine Phase 3 NCT05810038 A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects. COMPLETED
Rimegepant/BHV3000 Migraine Phase 3 NCT04649242 Randomized Study in Children and Adolescents With Migraine: Acute Treatment RECRUITING